The United States has announced it will reclassify state-licensed medical marijuana as a less dangerous drug, a step in line with a growing trend away from penalising its possession. Schedule III is for substances with “a moderate to low potential for physical and psychological dependence”.
“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,” Acting Attorney General Todd Blanche said in a statement.
A 2024 poll by the Pew Research Center found that 57 percent of US adults said that marijuana should be legal for both recreational and medical purposes, while 32 percent indicated it should only be legal for medical purposes. Just 11 percent said the drug should not be legal at all.